Britain’s Talent for technology
Do we have the right skills and capabilities in place to identify and develop the next generation of ATMPs?
FACILITATED BY
JAMES STRACHAN | Editor | The Cell + Gene Curator
PANELLISTS INCLUDE
NICK STEPHENS | Executive Chairman | The RSA Group
CHRIS NOWERS | Chief Executive Officer | ONK Therapeutics
CHARLOTTE CASEBOURNE | Chief Executive Officer and Co-founder | Theolytics
STEPHEN WARD | Chief Manufacturing Officer| Cell and Gene Therapy Catapult
COLIN MACKAY | Founder and CEO | Symbiosis Pharmaceutical Services Ltd